Russell Frank Company’s Trinity Biotech TRIB Stock Holding History

Russell Frank Company’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$5.28M	Buy	90,596 +16,609	+22%	+$881K	0.01%	1296
2015 Q4	$4.44M	Sell	73,987 -18,548	-20%	-$1.09M	0.01%	1361
2015 Q3	$5.29M	Buy	92,535 +2,226	+2%	+$179K	0.01%	1239
2015 Q2	$8.15M	Buy	90,309 +46,507	+106%	+$4.03M	0.01%	1125
2015 Q1	$4.22M	Buy	43,802 +4,640	+12%	+$429K	0.01%	1348
2014 Q4	$3.42M	Buy	39,162 +5,360	+16%	+$462K	0.01%	1500
2014 Q3	$3.09M	Buy	33,802 +1,460	+5%	+$158K	0.01%	1542
2014 Q2	$3.72M	Buy	32,342 +5,889	+22%	+$698K	0.01%	1457
2014 Q1	$3.21M	Buy	26,453 +5,840	+28%	+$766K	0.01%	1532
2013 Q4	$2.54M	Buy	20,613 +4,635	+29%	+$556K	﹤0.01%	1588
2013 Q3	$1.74M	Buy	15,978 +4,842	+43%	+$472K	﹤0.01%	1936
2013 Q2	$938K	Buy	+11,136	New	+$924K	﹤0.01%	2094

Other funds holding TRIB

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Russell Frank Company's TRIB Position: Q1 2016 in Review

Russell Frank Company increased its Trinity Biotech (TRIB) stake by 22% in Q1 2016, buying an estimated $881K and bringing the position to 90,596 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #1296.

Russell Frank Company first reported a position in TRIB in Q2 2013 and has held it in 12 quarters since. The position peaked at $8.15M in Q2 2015. 79 funds tracked by Wall St. Rank hold TRIB as of Q1 2016.

Russell Frank Company held 90,596 shares of Trinity Biotech worth $5.28M as of Q1 2016.
Russell Frank Company bought 16,609 Trinity Biotech shares in Q1 2016, an estimated $881K.
Trinity Biotech made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1296 holding.
Russell Frank Company first reported a position in Trinity Biotech in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Trinity Biotech position peaked at $8.15M in Q2 2015.
79 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.